►
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
A
B
A
E
Okay,
perfect,
so
we
have
a
quorum
established
and
are
prepared
to
do
business.
We
have
some
special
guests
with
us
today
that
I
would
just
like
to
make
a
few
introductions.
I
have
some
constituents
with
me
today,
tom
and
dana
kohler.
Thank
you
very
much
for
being
here.
E
If
you
can
just
wave
your
hand,
thank
you,
and
we
have
a
a
lot
of
distinguished
guests
with
us
today
who
have
flown
in
and
come
in
to
speak
on
some
very
special
bills,
important
bills
this
morning
and
everyone
will
obviously
introduce
themselves
later,
but
I
was
pleasantly
surprised
to
see
my
good
friend
dr
mike
giesky
here
with
us
this
morning.
So
thanks
for
being
here,
do
we
have
any
other
introductions?
E
F
Thank
you,
chairwoman
moser,
I'm
jim
duplessy
district,
25
state
representative
out
of
hardin
county
on
the
zoom
call.
We
have
dr
cheryl
levinson
phd,
associate
professor
at
university
of
louisville
and
also
founder
of
the
I'm
going
to
mess
this
up
the
eating
order,
just
eating
disorder
clinic
in
louisville
kentucky,
dr
leveson.
Would
you
like
to
introduce
yourself.
B
Sure
hi
everyone
I'm
dr
levinson
as
said
I'm
faculty
at
university
of
louisville,
where
I
direct
the
eating
anxiety,
treatment,
research
lab
and
I'm
also
founder
and
clinical
director
at
louisville
center
for
eating
disorders,
which
is
the
only
eating
disorder
specialty
clinic
in
the
state
of
kentucky
where
we
offer
a
higher
level
of
care
and
outpatient
services.
So
excited
to
be
here
today
to
talk
about
expanding
access.
F
Thank
you
doctor.
The
reason
I'm
here
is,
I
had
a
constituent
come
to
me
whose
child
was
receiving
services
from
the
clinic
in
louisville,
said
said:
child
was
with
the
family
on
vacation.
I
don't
know
if
they
had
an
anxiety
issue
or
what
but
needed
to
talk
to
their
counselor,
but
the
counselor
was
like
we're
not
allowed
to
do
overstate
lines.
F
If
you
need
to
talk
to
your
counselor,
we
need
to
make
sure
it's
a
state
that
we've
made
that
able
to
be
done,
and
this
bill
does
that
in
a
nutshell,
it's
a
really
simple
bill.
It.
It
says
that
the
counselor
or
excuse
me
not
not
the
counselor,
the
the
practitioner,
whether
it's
a
doctor
or
therapist,
they
must
be
licensed
and
certified
in
the
state
of
kentucky.
F
They
can't
be
in
the
and
the
patient
must
be
a
permanent
resident
of
kentucky
and
that
that
resident.
If
they
are
temporarily
out
of
state,
they
can
reser
receive
services.
So
that's
basically
in
a
nutshell,
what
the
bill
does.
It
has
reciprocity
for
other
states
in
it
as
well.
F
D
Just
quickly,
I
want
to
thank
you
for
making
yourself
available
to
I'm
sure
everybody
on
the
committee
and
answering
some
questions,
and
the
fact
that
there's
no
opposition
here
at
all
makes
us
pretty
this
bill
looked
like
something
we
definitely
need.
So
thanks
a
lot
for
allowing
us
to
to
engage
prior
to
this.
Even
thank
you
very
much.
Thank
you,
representative.
E
D
C
D
G
I'd
like
I'd
like
to
make
a
comment
and
that
being
that
the
acceptance,
because
of
covid
of
the
mental
health
industry
and
the
importance
in
our
country
is
one
good
outcome
of
a
horrible
situation
for
the
past
two
years.
So
I
thank
you
for
the
work
you're
doing
and
I
vote
yes
for
this
representative.
E
E
F
E
You,
okay,
we
do
have
house
bill
92
on
the
agenda
and
just
to
let
members
know
we
will
be
passing
over
this
today,
because
there
was
a
committee
sub
in
the
works
and
the
attorney
general
still
had
some
questions
to
work
through
with
some
of
the
stakeholders
so
expect
to
see
that
another
time
but
not
today,
I
will
be
passing
the
gavel
to
my
co-chair
and
coming
to
the
table
to
present
two
bills
today
house
bill
219
will
be
the
first
bill
that
we
take
up
lung
cancer
screening.
E
H
Do
I
hear
a
second
second,
how
many
second
voice
vote
all
in
favor
say
aye
opposed.
You
may
proceed
perfect.
Thank
you.
E
This
is
why
this
bill
is
just
so
critical.
It's
modeled
after
the
colon
cancer
screening
program
that
we
put
in
place
in
kentucky
and
we've
seen
great
results
from
that,
seeing
our
colon
cancer
screening
rates
really
increase
and
early
detection
rates
improve.
So
this
is
modeled.
After
that
provision.
E
E
But
what
this
legislation
does
simply
is
establishes
a
restricted
fund
for
the
assistance
of
any
eligible
kentucky
resident
for
lung
cancer
screening,
and
then
it
establishes
a
lung
cancer
screening
advisory
council,
including
experts
and
stakeholders,
to
review
relevant
data
clinical
guidelines
and
best
practices
for
lung
cancer
screening
and
also
provides
oversight
and
annual
reporting
on
the
implementation
and
outcomes.
So
I
will
hand
it
off
to
whoever
wants
to
go.
First.
I
I
Here
in
kentucky
for
over
25
years,
the
work
that
we've
done
at
markey
cancer
center
has
been
successful
to
be
able
to
enhance
the
quality
of
lung
cancer
surgery
and
while
we
are
often
successful
with
our
operations
on
early
stage,
lung
cancer
surgeons
are
universally
frustrated
by
the
fact
that
only
15
to
18
percent
of
lung
cancer
discovered
in
that
early
phase,
and
so
as
mentioned,
the
opportunity
to
be
able
to
have
more
success
with
treating
patients
at
an
earlier
stage
is,
is
optimal.
It's
also
less
expensive.
I
It
doesn't
involve
getting
into
the
costs
of
the
later
stage,
drugs
and
more
extensive
radiation
therapy
and
other
treatments,
and
so
unfortunately,
kentucky
does
lead
the
country
in
mortality
from
this
disease
and
up
until
last
year
we
were
leading
the
country
in
incidents
for
this
disease
as
well.
Now
we
are
number
two
and
that's
progress
for
us
in
a
state
that
has
borne
the
burden
of
lung
cancer
for
so
long.
I
Screening
rates
remain
low
around
six
percent
for
eligible
patients.
Those
people
that
meet
the
specific
criteria
for
qualifying
for
a
low
dose
ct
scan
can
participate
in
this,
but
this
number
pales
in
comparison
to
that
of
breast
colon,
cervical
cancer,
which
have
been
much
more
successful
over
time
with
as
much
cancer
as
we
have
in
kentucky.
We
don't
have
time
and
we
need
to
accelerate
our
movement
of
lung
cancer
screening
since
2015.
I
I
and
many
colleagues
led
by
markey
cancer
center
colleagues
like
dr
giese,
dr
flores
program
folks
across
the
state
in
many
community
programs,
have
participated
in
a
research
project
called
the
kentucky
leads
collaborative,
and
this
has
helped
us
to
be
able
to
drive
kentucky
screening
rates
to
the
number
two
in
the
country.
Second,
in
the
country,
something
that
kentucky
doesn't
normally
see
in
the
rates
of
lung
disease
or
in
cancer
activity.
So
this
is
this
is
huge:
we've
gotten
almost
a
20
percent,
that's
not
enough!
I
I
Lung
cancer
screening
has
been
proven
to
be
effective,
it
can
fight
our
lung
cancer
screening
rate
and
it's
only
been
active
for
less
than
10
years,
and
so
we've
already
seen
a
10
percent
reduction
in
late
stage,
diagnosis,
that's
something
that
we
haven't
seen
ever
and
so
it's
beginning
to
take
effect,
but
it's
not
evenly
distributed.
We
need
to
be
more
effective
at
getting
improved
access
to
lung
cancer
screening
and,
most
importantly,
defining
the
quality
of
lung
cancer
screening.
I
J
J
J
That
causes
a
great
deal-
and
I
know
my
son
is
a
victim
of
that
there
and
fortunately
he's
in
remission
right
now,
and
I
had
a
doctor
friend
of
mine
who
would
tell
his
patients
to
stop
smoking.
Then
he'd
light
up
a
cigarette
before
they
left
the
room.
He
died
of
it
at
40
years
old.
So
this
is
good
legislation
and
I
encourage
the
members
to
vote
for
it
and
pass
this
legislation.
Thank
you.
Miniature.
H
K
Yeah,
I
can
go
ahead
and
I'll
go
next.
I'm
dr
michael
gieske,
I'm
a
family
practitioner.
I've
been
in
practice
for
over
35
years
now,
and
I
grew
up
in
edgewood
kentucky
right
at
the
site
of
our
flagship
hospital,
st
elizabeth
edgewood,
where
we
have
a
beautiful
new
state
of
the
art
cancer
center.
I
was
asked
to
join
our
thoracic
oncology,
disease
management
team
in
2016
as
the
primary
care
representative.
K
K
I've
for
three
decades
I
dealt
with
lung
cancer
patients
that
presented
to
my
office
with
this
dismal
prognosis,
and
there
was
a
sense
of
helplessness
and
hopelessness
for
both
myself
and
my
patients
and
their
families
as
well.
We
now
have
a
mechanism
to
go
after
lung
cancer
to
find
it
in
the
earliest
stages,
with
a
low
dose
ct
lung
cancer
screen.
If
we
find
lung
cancer
in
the
earliest
stages
stage,
one
we
have
a
greater
than
ninety
percent
chance
of
curing
that
cancer.
K
We
have
patients
with
stage
three
and
stage
four
lung
cancer
now,
even
when
we
find
it
in
these
later
stages,
that
are
have
been
alive
for
10
to
15
years,
with
no
evidence
of
disease.
So,
even
when
we
find
lung
cancer
in
the
later
stages,
we
can
make
a
dramatic
difference.
At
st
elizabeth
healthcare,
we've
built
a
quite
an
impressive
team.
It's
been
a
collaborative
effort,
we
have
as
a
a
foundational
component
of
our
screening
program,
the
nodule
review
board.
It's
made
up
of
a
pulmonologist,
a
radiologist
and
a
thoracic
surgeon,
I'm
there.
K
We
have
two
nurse
navigators
we
meet
every
monday
morning
bright
and
early
at
7
00
a.m.
We
review
all
of
the
suspicious
scans
from
our
program
and
the
incidental
scans
that
come
in
as
well
that
are
suspicious.
The
nurse
navigator
is
a
critical
component
of
this.
We
consider
them
the
glue
for
our
program.
They
really
help
to
guide
the
patient
through
every
step
of
the
process.
K
It's
also
key
to
buying
to
getting
the
buy-in
of
the
primary
care
providers
and
the
physicians
that
order
these
tests.
They
know
that
when
they
order
a
test,
they
enter
our
program
that
they're
going
to
be
provided
very
comprehensive
and
coordinated
care,
and
they
can
pretty
much
take
their
hands
off
the
steering
wheel
and
we
guide
the
patients
through
this
process.
K
K
We
are
finding
one
cancer,
lung
cancer
for
every
64
lung
cancer
screens
that
we
do,
and
when
people
hear
that
statistic
I
mean
that
really
is
impactful
out
of
those
cancers
that
we
find
we're
finding
55
percent
of
them
in
stage
1.
we're
finding
69
percent
in
the
early
stages
stage,
1
or
stage
2..
So
we
are
definitely
making
a
difference.
We
are
cause
causing
a
shift
from
high
stages
of
lung
cancer,
low
stages
of
lung
cancer.
We
can
make
a
tremendous
difference
in
our
system.
K
K
Through
our
process
we
are
expanding
out
and
we're
involved
in
a
lot
of
state-based
initiatives.
We
work
with
tim
mullen
and
their
crew
at
uk
and
the
uk
and
markey
cancer
center
we've
been
involved
in
the
kentucky
leads
project.
We
work
with
the
kentucky
cancer
project,
the
kentucky
cancer
foundation
and
lately,
over
the
last
two
years,
we've
worked
very
closely
with
the
kentucky
health
collaborative.
K
We
have
andrea,
sloan
and
evan
hackney
here
with
us
today,
as
representatives,
we
have
picked
lung
cancer,
lung
cancer
screening,
as
our
first
quality
measure
and
one
of
the
most
exciting
things
that
we're
doing
is.
We
have
got
10
hospital
systems
in
the
state
of
kentucky
that
collectively
provide
care
for
over
60
percent
of
our
state
to
agree
to
share
data.
We
have
gotten
all
the
signatures,
it's
kind
of
working
its
way
through
uk
and
the
the
the
it
collecting
department
down
there
we're
literally
days
off
of
completing
this
process.
K
Our
state
will
be
able
to
share
data,
we'll
be
able
to
benchmark
this
data,
we'll
be
able
to
build
quality
improvement
initiatives
around
this
data
and
really
make
a
difference.
We'll
know
where
the
disparities
lie,
we'll
know
how
to
go
after
them,
so
we
are
witnessing,
as
tim
said,
a
dramatic
turnaround
in
our
state.
We
will
be
number
one
in
the
country
by
end
of
this
year.
That's
my
bet
and
we
are
setting
the
bar
for
lung
cancer
screening
for
lung
cancer,
diagnosis
and
treatment
and
management,
and
we
are
making
a
huge
difference.
C
Well
well
said
mike
I'm
doug
floyer.
I
run
the
cancer
programs
up
here
at
st
elizabeth
over
about
five
different
hospitals,
and
I
appreciate
your
time
and
represent
moser.
Thank
you
for
the
forum.
I
think
you
guys
probably
have
recognized
the
passion
that
these
two
doctors
speak
with,
and
it's
a
it.
It's
enlightening
for
the
rest
of
us
across
the
state
to
see
these
two,
not
just
leading
this
discussion
regionally
but
nationally.
C
You
know
dr
giesky
is
involved
at
just
about
every
level
that
you
can
be
involved
in
lung
cancer
screening
and
is
now
considered
a
subject
matter
expert
nationally.
Dr
mullet's
been
doing
this
for
20
years
and
when
you
put
the
two
of
these
two
together,
it's
it's
quite
impressive
for
the
rest
of
us
that
are
sort
of
following
in
their
wake.
I
will
say
to
speak
to
dr
gusky
statistics.
C
C
So
it's
one
of
those
opportunities
for
the
legislator
and
you
to
understand
as
a
parent
as
a
brother
or
as
a
sister,
that
you
can
also
make
cost
effective
and
long-reaching
implications.
With
these
decisions
that
you
make
today,
I
will
say
that
you've
mentioned
appropriately
that
the
model
is
set
with
colon
we
climb
from
39th
in
the
country
to
17th
in
a
matter
of
three
or
four
short
years.
C
Our
health
care
system
now
has
prioritized
that
we're
up
to
about
83
percent
for
our
colorectal
cancer
screening
because
of
the
efforts
of
bodies
like
this
and
the
outreach
and
education
that
was
made
available
through
resources
that
we
gained
from
the
colon
cancer
consortium
stuff
and
we're
now
leading
the
country
at
49
percent.
But
that
means
half
of
these
long
cancer
patients
never
have
a
chance
for
dr
mullet
to
cure
him,
and
so
I
think
it's
compelling
so
I'll
close
by
thanking
you
all
for
your
attention.
C
I
brought
out
my
it's
a
beautiful
day
to
save
lives
mug
in
honor
of
these
festivities,
and
thank
you
for
for
kim
for
bringing
us
to
light.
H
Thank
you
for
your
testimony.
We
do
have
a
couple
of
questions
representative,
dotson,.
D
Thank
you,
madam
chair.
First
of
all,
I'd
like
to
say
this
is
a
great
piece
of
legislation,
but
I
have
a
two-part
question
doctor.
You
said
that
kentucky
is
number
one
in
late
stage:
lung
cancer.
What
do
you
feel
is
the
driving
force
behind
that,
and,
secondly,
do
you
feel
like
there's
any
connection
to
the
coal
industry
from
coal-fired
plants
to
coal
mining,
just
kind
of
want
to
get
your
take
on
what
makes
us
that
number.
I
I
One
of
them
is
is
a
culture
that
has
been
driven
by
years
of
understanding
that
when
you
find
lung
cancer,
it's
found
in
late
late-stage
disease,
and
why
should
I
bother
there's
a
bit
of
fatalism
associated
with
patients,
and
so
they
are
not
looking
for
this
disease
and
lung
cancer.
Screening
has
not
been
on
the
horizon
for
many
years,
and
so
the
culture
has
been
one
of
looking
for
this
disease
is
only
to
find
a
lethal
diagnosis,
and
so
many
patients
are
not
looking
in
that
direction.
I
Again.
Lung
screening
has
not
been
around
for
many
years,
so
we
haven't
had
a
chance
to
make
this
transition,
like
we've
seen
for
decades
with
breast
cancer
with
colon
cancer
in
the
last
20
years,
and
so
I
think
that-
and
the
other
of
course,
is
that
lung
cancer
is
only
symptomatic
when
it
has
already
spread
to
someplace
else.
I
The
small
tumors
that
I
take
out
for
lung
cancer
that
are
effectively
stage
1
or
early
stage
2
disease,
don't
cause
any
symptoms
at
all,
and
so
patients
never
know
they
have
it,
and
so
it's
only
when
it
is
spread
to
some
place
else
that
they
wind
up
with
pain,
weight
loss,
others.
The
second
question
regarding
exposure,
I
think,
is
important:
the
coal
industry
and
coal
fired
plants
and
others
there.
I
There
certainly
is
a
correlation
with
with
air
quality,
but
I
think
that
it's
not
necessarily
been
connected
with
the
coal
industry
like
black
lung
or
coal
workers.
Pneumoconiosis
is
associated
with
that.
I
There
is
a
correlation,
though,
with
population
that
works
in
the
mines
and
with
tobacco
exposure,
and
so
I
think
that
it's
difficult
to
dissect,
there's
often,
of
course,
and
and
representative
burch,
was
correct-
that
I
didn't
mention
tobacco
there's
a
tremendous
amount
of
stigma
associated
with
the
diagnosis
of
lung
cancer
and
a
bit
of
guilt
associated
with
the
diet
with
the
with
the
exposure
to
tobacco,
so
the
opportunity
to
be
able
to
dissect
separate
a
person
who
smokes
from
a
diagnosis
of
lung
cancer
is
really
important,
because
the
truth
is
the
majority
of
patients
when
they
are
diagnosed
with
lung
cancer
are
not
smoking,
and
so
it's
difficult
for
us
to
burden
them
with
the
diagnosis
of
tobacco
use.
I
G
And
I
you
know:
I've
had
to
question
myself
after
our
meeting
in
louisville
this
summer.
Talking
about
health
care
and
the
ranking
of
kentucky,
we
virtually
are
the
worst
state
as
far
as
health
care,
personal
health
care
in
in
the
country,
and
so
after
23
years
of
being
in
the
general
assembly.
I
wonder
what
the
root
is.
Why
do
people
not
love
themselves
enough
to
take
care
of
themselves
and
how
do
we
get
them
to
learn
to
make
a
difference
in
in
their
future,
their
their
entire
life?
G
And
I
would
say
that
screening
for
lung
cancer
is
incredible.
It's
a
it's
an
incredible
opportunity,
but
I
bet
it's
met
with
a
lot
of
fear
when
they
come
in
your
door,
and
I
really
hope
that,
with
the
success
you
have,
there
will
be
more
people
who
reach
out
to
you
at
an
earlier
stage.
That'll
cut
health
care
costs,
it'll,
give
them
much
longer
lifespan
and
give
me
hope
to
know
that
people
are
starting
to
love
themselves
enough.
Thank
you.
H
Motion
on
the
bill,
we
have
a
motion
on
the
bill
from
a
second
any
other
comments
before
we
vote.
E
Well,
I,
if
I
may,
I
would
just
like
to
really
thank
my
experts
here
today.
I
I
don't
know
that
there's
a
whole
lot
that
I
can
say
that
they
haven't
said
and
and
have
said
so
eloquently,
but
I
I
would
just
really
implore
everyone
to
support
this,
and
certainly
recommendations
can
be
made
for
preventative
initiatives
out
of
the
advisory
council
as
well,
and
I
would
just
like
to
thank
dr
flora
for
taking
such
good
care
of
my
mom
when.
C
D
I
D
H
Passes
unanimously
and
should
pass
favorably
on
the
house
floor.
Thank
you
all
for
your
testimony.
As
that
current
legislative
liaison
to
the
colon
cancer
advisory
committee.
I
know
the
great
work
they've
done
and
this
probably
should
have
been
done
a
long
time
ago,
but
we're
we'll
move
forward.
So
thank
you
all
for
being
here
today
and
all
your
work.
Thank
you.
E
E
E
Thank
you,
madam
chair.
I
am
representative
kim
mosher
again
I
represent
the
64th
district
and
I
have
some
very
great
experts
with
me
today
to
help
me
discuss
what
really
is
a
an
update
and
a
cleanup
of
senate
bill
44
from
last
year
house
bill
317
is
well.
Last
year
we
we
passed
senate
bill
44,
which
allowed
charitable
organizations
to
pay
premiums
and
co-pays
for
low-income
patients,
and
what
happened
last
year
was
an
amendment
was
placed
on
senate
bill
44
that
intended
to
prevent
some
bad
actors
from
taking
advantage
of
the
system.
E
Unfortunately,
it
has
become
clear
that
the
language
was
went
a
bit
too
far.
It
was
a
bit
too
far-reaching
and
could
have
had
some
unintended
consequences,
and
so
we're
going
to
talk
about
that
today,
the
bril
the
bill
I
bring
before
you
today
house,
bill
317
closes
that
loophole
that
the
amendment
created,
but
it
still
prohibits
the
bad
actors
from
taking
advantage
of
patients
or
their
insurers.
E
For
for
those
low-income
people,
this
is
incredibly
important,
particularly
in
in
our
current
climate
during
the
pandemic.
This
is
a
patient
patient-centered
bit
of
legislation
that
will
ensure
continuity
of
care
for
people
who
are
dealing
with
a
health
crisis,
and
we
have
some
some
members,
some
guests
today
to
talk
about
some
of
those
health
issues.
E
It's
it
has
been.
This
was
an
advisory
opinion
that
required
the
organization
to
adhere
to
strict
federal
guidelines
and-
and
there
are
some
some
strict
guidelines
that
we
can
talk
about.
If,
if
there
are
questions
about
those,
so
the
guidelines
that
most
non-profits
with
patient
assistance
programs
already
adhere
to,
they
already
adhered.
All
of
these,
for
example,
the
american
kidney
funds
program
guard
rails
are
actually
even
stricter
than
what
the
federal
guidelines
put
in
place.
E
We
believe
that
what
is
contained
in
this
bill
is
more
than
sufficient
to
protect
against
any
fraud
or
any
abuse,
and
still
make
sure
that
patients
are
able
to
receive
the
support
that
they
need.
So
I
would
like
to
just
pass
the
microphone
off
to
some
of
my
guests
and
please
introduce
yourself
for
the
record.
L
It
is
good
afternoon
chairwoman
moser
vice
chairman
woman,
gibbons-prenty
and
members
of
the
committee.
My
name
is
melanie
londonell,
I'm
with
the
american
kidney
fund,
and
I'm
here
today
to
respectfully
request
your
support
for
house
bill
317,
really
in
order
to
ensure
that
non-profit
organizations
like
ours
can
continue
to
help.
Low-Income
patients
receive
the
health
care
that
they
need
that
they
believe
best
meets
their
individual
needs.
L
L
L
Our
program,
to
be
sure,
is
a
hundred
percent
needs
based.
It
accepts
patients
for
grants
based
on
a
first
come
surf
first
serve
basis,
and
one
thing
that
is
important
to
mention
is
that
patients
come
to
us
seeking
grant
assistance
having
already
chosen
their
insurance.
We
don't
opine
nor
discuss
the
choice
of
insurance.
L
And
and
finally-
and
this
is
probably
one
of
the
most
important
parts
of
our
program-
is
that
our
assistance
increases
the
likelihood
that
someone
will
get
a
kidney
transplant.
A
patient
is
not
placed
on
the
transplant
waiting
list
unless
they
are
fully
insured
and
by
assisting
people
with
their
health
insurance.
We
ensure
that
they
have
the
opportunity
to
get
on
the
transplant
list,
which
increases
their
likelihood
of
receiving
a
kidney
transplant.
L
Our
goal,
ultimately
is
to
create
a
world
without
kidney
disease,
but
until
that
time
our
hip
program
ensures
that
patients
have
the
health
care
coverage
that
they
need
are
able
to
access
the
health
care
coverage
that
they
need
and
that
they
believe
best
meets
their
individual
health
care
needs.
So,
thank
you.
So
much
chairwoman
moser
for
bringing
this
bill
forward.
We
are
so
grateful
to
you
and
to
all
of
the
members
of
the
committee
for
considering
this
today.
M
Motion
on
the
bill,
thank
you,
chairwoman,
moser
and
members
of
the
committee.
My
name
is
jeb
mcgrath
and
I'm
the
executive
director
of
the
epilepsy
foundation
of
kentuckiana
on
behalf
of
the
173
461
kentuckians,
who
suffer
from
epilepsy,
also
known
as
a
seizure
disorder
who
may
need
assistance
in
paying
their
health
insurance
premium.
I
would
like
to
thank
chairwoman
moser
for
introducing
house
bill
317.
M
M
The
foundation
has
an
annual
fundraising
event,
that
is
the
primary
source
of
funding
needed
to
help
the
individuals
we
serve.
The
tremendous
financial
support
we
receive
from
health
care
providers
who
attend
our
fundraisers
are
key
to
the
success
of
that
fundraiser.
A
provision
in
senate
bill
44
from
2021
allows
an
insurance
company
to
reject
insurance
premium.
Assistances
from
the
epilepsy
foundation,
because
we
receive
funding
from
health
care
providers
through
our
annual
fundraiser
house
bill
317
would
correct
this
unintentional
exclusion
so
that
we
may
continue
to
help
families
in
need.
H
Eye
on
this
bill,
I
may
add
one
thing:
please
record
that
I
am
in
the
in
the
room
and
record
a
yes
vote
for
it.
Hb
188,
as
well
as
219.
C
B
H
D
Yes,
I'm
sorry
can,
I
say,
run
real
quick.
Thank
you
very
much
for
just
this
wonderful
cleanup.
We
don't
always
get
it
right
and
that's
obvious,
sometimes,
but
glad
that
we
were
able
to-
and
this
really
is
a
great
example.
D
N
Yes,
if
I
may
comment,
please,
I
sincerely
appreciate
you
bringing
this
bill
forward.
My
father
suffered
from
kidney
disease
for
several
years,
so
while
he
would
not
benefit
from
this,
I've
met
several
people
who
would
certainly
benefit
from
this
bill,
and
so
I
and
this
initiative-
and
so
I
sincerely
appreciate
you
doing
this,
so
thank
you
very
much
and
I
would
like
to
vote
yes.
H
Pastor,
jim
unanimously,
and
should
be
favorably
on
the
house
floor,
so
thank
you
very
much.
Thank
you
all
for
your
testimony.
Thank
you.
H
Would
you
like
to
record
some
other
votes,
please
thank
you.
Ma'am
chair.
Yes,
please
register
a
vote.
Yes
for
me
for
hp
188
as
well
as
219.,
okay,
being
there
no
further
business.
Our
motion
for
adjournment.